This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headwinds Persist, Major Markets Down 3rd Straight Day: DAL, AAL, UAL, WBA
by Mark Vickery
It's the third-straight day in the red for the Dow, S&P 500 and Nasdaq, which fell 0.07%, 0.15% and 0.47%, respectively.
Walgreens Boots (WBA) Q4 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal fourth-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
Walgreens Boots Alliance (WBA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 6.25% and 1.08%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Important Earnings Chart to Watch This Week
by Tracey Ryniec
There are more than just banks reporting this first week of earnings season.
Evaluating Struggling Walgreens (WBA) Stock Ahead of Q4 Earnings
by Benjamin Rains
Walgreens Boots Alliance (WBA) hasn't gained any sustained momentum during the market comeback, with the stock down 37% in 2020, against the S&P 500's 8% jump...
Will Walgreens (WBA) Post Dull Retail Numbers in Q4 Earnings?
by Zacks Equity Research
Walgreens' (WBA) retail pharmacy international sales remain dull in Q4 on difficult market scenario in the U.K.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens' Pharmacy International Arm Faces Coronavirus Woes
by Zacks Equity Research
Walgreens (WBA) expects the adverse impact of COVID-19 to continue in the fiscal fourth quarter.
Rite Aid (RAD) Surpasses Earnings & Sales Estimates in Q2
by Zacks Equity Research
Rite Aid's (RAD) Q2 results gain from solid demand, rise in same-store prescription count, strength in Elixir brand and cost-cutting plans.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $37.17 in the latest trading session, marking a +1.12% move from the prior day.
Walgreens (WBA) Up 6.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rite Aid Continues Expansion of Coronavirus Testing Sites
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 161 more sites in order to curb the effects of coronavirus.
Company News for Jul 10, 2020
by Zacks Equity Research
Companies In The News Are: BBBY, WBA, HELE, WFC.
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.
Company News for Jul 9, 2020
by Zacks Equity Research
Companies In The News Are: KKR, TMHC, WORK, WBA.
Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -24.55% and 1.59%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
Tech Stocks Continue to Surge Higher
by Jeremy Mullin
The Nasdaq continues to hit highs despite the rise in COVID-19 cases.
Buy Beaten-Down Walgreens (WBA) Stock Ahead of Earnings?
by Benjamin Rains
Walgreens reports its Q3 FY20 financial results before the opening bell on Thursday, July 9. The question is should investors consider buying shares of the struggling pharmacy chain?
JPMorgan, FedEx, Oracle, Walgreens and Paycheck are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, FedEx, Oracle, Walgreens and Paycheck are part of Zacks Earnings Preview
Pharmaceutical Wholesale to Aid Walgreens' (WBA) Q3 Earnings?
by Zacks Equity Research
Walgreen Boots' (WBA) international businesses in the third quarter is likely to have suffered a huge blow with international trade coming almost to a standstill.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Jul 2, 2020
by Zacks Equity Research
The Nasdaq and the S&P 500 closed higher on Wednesday as investors focused on signs of economic recovery and better than expected economic data.
What Will Push Stocks Higher?
by Sheraz Mian
We have seen some good economic data in recent days, with the June factory sector ISM and payroll numbers showing impressive momentum. So what will push stocks higher next?
Walgreens' Retail Pharmacy Grows Amid Coronavirus Crisis
by Zacks Equity Research
Walgreens' (WBA) tie-ups with Alphabet's life sciences and healthcare segment, Verily on multiple projects related to chronic ailments buoy optimism.
Rite Aid Adds More Testing Sites in Fight Against Coronavirus
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 21 more sites in order to curb the effects of coronavirus.